1. Home
  2. PULM vs HCTI Comparison

PULM vs HCTI Comparison

Compare PULM & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • HCTI
  • Stock Information
  • Founded
  • PULM 2003
  • HCTI 2020
  • Country
  • PULM United States
  • HCTI United States
  • Employees
  • PULM N/A
  • HCTI N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • PULM Health Care
  • HCTI Technology
  • Exchange
  • PULM Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • PULM 33.2M
  • HCTI 13.5M
  • IPO Year
  • PULM N/A
  • HCTI 2021
  • Fundamental
  • Price
  • PULM $6.61
  • HCTI $0.03
  • Analyst Decision
  • PULM
  • HCTI
  • Analyst Count
  • PULM 0
  • HCTI 0
  • Target Price
  • PULM N/A
  • HCTI N/A
  • AVG Volume (30 Days)
  • PULM 62.2K
  • HCTI 714.4M
  • Earning Date
  • PULM 08-12-2025
  • HCTI 08-18-2025
  • Dividend Yield
  • PULM N/A
  • HCTI N/A
  • EPS Growth
  • PULM N/A
  • HCTI N/A
  • EPS
  • PULM N/A
  • HCTI N/A
  • Revenue
  • PULM $1,921,000.00
  • HCTI $11,291,000.00
  • Revenue This Year
  • PULM N/A
  • HCTI N/A
  • Revenue Next Year
  • PULM $134.88
  • HCTI N/A
  • P/E Ratio
  • PULM N/A
  • HCTI N/A
  • Revenue Growth
  • PULM N/A
  • HCTI N/A
  • 52 Week Low
  • PULM $1.78
  • HCTI $0.01
  • 52 Week High
  • PULM $10.40
  • HCTI $1.90
  • Technical
  • Relative Strength Index (RSI)
  • PULM 39.23
  • HCTI 41.67
  • Support Level
  • PULM $6.65
  • HCTI $0.02
  • Resistance Level
  • PULM $7.20
  • HCTI $0.03
  • Average True Range (ATR)
  • PULM 0.91
  • HCTI 0.01
  • MACD
  • PULM -0.21
  • HCTI 0.01
  • Stochastic Oscillator
  • PULM 43.49
  • HCTI 50.86

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: